Skip to main content
. 2019 Feb 27;18(5):621–637. doi: 10.1080/15384101.2019.1580494

Table 3.

Up-regulated miR-202-3p and knockdown TRPM-6 result in declines in inflammatory response and Troponin.

Groups IL-1β/pg•mL−1 IL-6/pg•mL−1 TNF-α/pg•mL−1 Troponin T/pg•mL−1
Sham 59.05 ± 7.38 16.28 ± 2.83 10.73 ± 2.73 8.96 ± 2.79
I/R injury 129.36 ± 15.94* 56.55 ± 6.21* 51.51 ± 6.78* 49.39 ± 3.39*
NC 128.79 ± 14.88* 57.56 ± 6.47* 50.91 ± 6.95* 48.47 ± 3.34*
miR-202-3p mimic 89.83 ± 9.94*# 35.34 ± 4.41*# 29.57 ± 4.12*# 26.76 ± 3.21*#
siRNA-TRPM6 88.43 ± 9.14*# 35.14 ± 3.98*# 30.24 ± 3.12*# 27.33 ± 3.08*#
miR-202-3p inhibitor 184.45 ± 23.05*# 83.34 ± 13.14*# 78.78 ± 8.91*# 76.22 ± 4.12*#
miR-202-3p inhibitor + siRNA- TRPM6 129.13 ± 16.14* 56.34 ± 8.66* 51.76 ± 6.32* 50.29 ± 3.29*

*, p < 0.05 vs. the sham group; #, p < 0.05 vs. the I/R injury group; n = 5; multiple groups were compared by one-way analysis of variance followed by a Tukey’s post hoc test; NC, negative control; miR-202-3p, microRNA-202-3p; TRPM6, transient receptor potential cation channel, subfamily M, member 6; IL-1β, interleukin 1 beta; IL-6, interleukin 6; TNF-α, tumor necrosis factor-α.